PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center, Chula VRC), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\', \'Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\', \'Integrated Frontier Biotechnology for Emerging Disease, Chulalongkorn University, Bangkok, Thailand.\', \'Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\', \'Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\', \'Thai Red Cross Emerging Infectious Diseases-Health Science Centre, World Health Organization Collaborating Centre for Research and Training on Viral Zoonoses, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\', \'Institute of Biological Product, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.\', \'BioNet-Asia Co., Ltd, Bangkok, Thailand.\', \'Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0248007
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33750975
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all